Mentrik Biotech is a biopharmaceutical company dedicated to the optimization of oncology-based therapeutics. It develops AME-133v, an anti-CD20 monoclonal antibody. It is engineered for enhanced affinity to CD20 and increased antibody-dependent cell-mediated cytotoxicity (ADCC), and designed for improved treatment for low-affinity FcγRIIIa polymorphisms. The company also develops drug candidates for non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and systemic lupus erythematosus.
|HQ||Dallas, TX, US||Map|
|Employees (est.) (Jan 2021)||2|
When was Mentrik Biotech founded?
Mentrik Biotech was founded in 2010.
How many employees does Mentrik Biotech have?
Mentrik Biotech has 2 employees.
Who are Mentrik Biotech competitors?
Competitors of Mentrik Biotech include ImmVira, ASLAN Pharmaceuticals and Precision Medicines.
Where is Mentrik Biotech headquarters?
Mentrik Biotech headquarters is located at 5420 Lyndon B Johnson Fwy #410, Dallas.
Where are Mentrik Biotech offices?
Mentrik Biotech has an office in Dallas.
How many offices does Mentrik Biotech have?
Mentrik Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies